General Information of Disease (ID: DIS2Q1MH)

Disease Name Harmful effects of drugs, medicaments or biological substances
Disease Class NE60: Drugs/medicaments/biological substances harmful effect
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DIS2Q1MH: Harmful effects of drugs, medicaments or biological substances
ICD Code
ICD-11
ICD-11: NE60
Expand ICD-11
'NE60
Expand ICD-10
'T36-T50; 'T36; 'T36.0; 'T36.1; 'T36.2; 'T36.3; 'T36.4; 'T36.5; 'T36.6; 'T36.7; 'T36.8; 'T36.9; 'T37; 'T37.0; 'T37.1; 'T37.2; 'T37.3; 'T37.4; 'T37.5; 'T37.8; 'T37.9; 'T38; 'T38.0; 'T38.1; 'T38.2; 'T38.3; 'T38.4; 'T38.5; 'T38.6; 'T38.7; 'T38.8; 'T38.9; 'T39; 'T39.0; 'T39.1; 'T39.2; 'T39.3; 'T39.4; 'T39.8; 'T39.9; 'T40; 'T40.0; 'T40.1; 'T40.2; 'T40.3; 'T40.4; 'T40.5; 'T40.6; 'T40.7; 'T40.8; 'T40.9; 'T41; 'T41.0; 'T41.1; 'T41.2; 'T41.3; 'T41.4; 'T41.5; 'T42; 'T42.0; 'T42.1; 'T42.2; 'T42.3; 'T42.4; 'T42.5; 'T42.6; 'T42.7; 'T42.8; 'T43; 'T43.0; 'T43.1; 'T43.2; 'T43.3; 'T43.4; 'T43.5; 'T43.6; 'T43.8; 'T43.9; 'T44; 'T44.0; 'T44.1; 'T44.2; 'T44.3; 'T44.4; 'T44.5; 'T44.6; 'T44.7; 'T44.8; 'T44.9; 'T45; 'T45.0; 'T45.1; 'T45.2; 'T45.3; 'T45.4; 'T45.5; 'T45.6; 'T45.7; 'T45.8; 'T45.9; 'T46; 'T46.0; 'T46.1; 'T46.2; 'T46.3; 'T46.4; 'T46.5; 'T46.6; 'T46.7; 'T46.8; 'T46.9; 'T47; 'T47.0; 'T47.1; 'T47.2; 'T47.3; 'T47.4; 'T47.5; 'T47.6; 'T47.7; 'T47.8; 'T47.9; 'T48; 'T48.0; 'T48.1; 'T48.2; 'T48.3; 'T48.4; 'T48.5; 'T48.6; 'T48.7; 'T49; 'T49.0; 'T49.1; 'T49.2; 'T49.3; 'T49.4; 'T49.5; 'T49.6; 'T49.7; 'T49.9; 'T50; 'T50.0; 'T50.1; 'T50.2; 'T50.3; 'T50.4; 'T50.5; 'T50.6; 'T50.7; 'T50.8; 'T50.9; 'T96

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Ciraparantag DM9G026 Phase 2 NA [1]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Preclinical Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Andexanet alfa DMZK4DY Application submitted NA [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)